Editorial: methotrexate in patients with Crohn's disease refractory to anti‐TNF therapy—moving backwards yet forward? Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

LINKED CONTENTThis article is linked to Mesonero et al paper. To view this article, visit https://doi.org/10.1111/apt.16315

authors

Tandon, Parul
Narula, Neeraj

status

published

publication date

April 2021

has subject area

1103 Clinical Sciences (FoR)
1115 Pharmacology and Pharmaceutical Sciences (FoR)
Crohn Disease (MeSH)
Gastroenterology & Hepatology (Science Metrix)
Humans (MeSH)
Immunosuppressive Agents (MeSH)
Infliximab (MeSH)
Methotrexate (MeSH)
Registries (MeSH)
Tumor Necrosis Factor-alpha (MeSH)

published in

Alimentary Pharmacology and Therapeutics Journal